Owing to its large population base, Asia accounts for over 35% of the estimated global incidence of Renal cell carcinoma, with China, Japan, and India collectively contributing to over a quarter of the cases.

其他相關內容

2025/12/18 文章

In-Vivo CAR-T From Concept to Clinic – What It Will Take to Win the “Age of In-Vivo”

...

報告